【レポートの概要（一部）】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Nuclear Medicine Market, By Application
5.1 Introduction
5.2 Therapeutics
5.2.1 Bone Metastasis
5.2.2 Endocrine Tumors
5.2.3 Lymphoma
5.2.4 Thyroid
5.2.5 Nephrology
5.2.6 Cardiology
5.2.7 Neurology
5.2.8 Other Therapeutic Applications
5.3 Diagnostics
5.3.1 Positron Emission Tomography (PET)
5.3.1.1 Oncology
5.3.1.2 Neurology
5.3.1.3 Cardiology
5.3.1.4 Inflammation
5.3.1.5 Other PET Applications
5.3.2 Single Photon Emission Computed Tomography (SPECT)
5.3.2.1 Thyroid
5.3.2.2 Neurology
5.3.2.3 Lymphoma
5.3.2.4 Cardiology
5.3.2.5 Gastro Intestinal
5.3.2.6 Oncology
5.3.2.7 Nephrology
5.3.2.8 Inflammation
5.3.2.5 Other Diagnostic Applications
6 Global Nuclear Medicine Market, By Type
6.1 Introduction
6.2 Nuclear Medicine Therapeutic Isotopes
6.2.1 Alpha Emitters
6.2.1.1 Thorium-227 (Th-227)
6.2.1.2 Radium-224
6.2.1.3 Radium-223
6.2.1.4 Lead (Pb-212)/Bismuth (Bi-212)
6.2.1.5 Astatine (At-211)
6.2.1.6 Actinium (Ac-225)
6.2.1.7 Others
6.2.2 Brachytherapy
6.2.2.1 Palladium-103
6.2.2.2 Iridium-192
6.2.2.3 Iodine-125
6.2.2.4 Cesium-131
6.2.2.5 Others
6.2.3 Beta Emitters
6.2.3.1 Yttrium-90 (Y-90)
6.2.3.2 Samarium-153 (SM-153)
6.2.3.3 Rhenium-186 (Re-186)
6.2.3.4 Lutetium-177 (Lu-177)
6.2.3.5 Iodine-131 (I-131)
6.2.3.6 Erbium (Er-169)
6.2.3.7 Strontium (Sr-89)
6.2.3.8 Others
6.3 Nuclear Medicine/Radiopharmaceuticals Diagnostics
6.3.1 Positron Emission Tomography (PET) Radiopharmaceuticals
6.3.1.1 Rubidium-82 (RB-82)
6.3.1.2 Fluorodeoxyglucose (FDG)
6.3.1.3 Gallium (Ga-68)
6.3.1.4 Others
6.3.2 Single Photon Emission Computed Tomography (SPECT)
6.3.2.1 Technetium-99m (TC-99m)
6.3.2.2 Thallium-201 (TL-201)
6.3.2.3 Gallium-67 (GA-67)
6.3.2.4 Iodine (I-123)
6.3.2.5 Samarium
6.3.2.6 Yttrium
6.3.2.7 Rhenium
6.3.2.8 Others
7 Global Nuclear Medicine Market, By Procedural Volume
7.1 Introduction
7.2 Therapeutic
7.2.1 Alpha Emitters
7.2.2 Beta Emitters
7.2.3 Brachytherapy
7.3 Diagnostics
7.3.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
7.3.2 Positron Emission Tomography (PET) Radiopharmaceuticals
8 Global Nuclear Medicine Market, By End User
8.1 Introduction
8.2 Academic Research Laboratories
8.3 Industries
8.4 Medical
8.4.1 Hospitals
8.4.2 Diagnostic Centers
9 Global Nuclear Medicine Market, By Stable Isotope
9.1 Introduction
9.2 Sulphur (S-32)
9.3 Oxygen (O-18)
9.4 Nitrogen (N-15)
9.5 Deuterium (D2)
9.6 Carbon (C-13)
9.7 Other Stable Isotopes
10 Global Nuclear Medicine Market, By Geography
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Advanced Accelerator Applications S.A.
12.2 Ashby Gorman Baker Ltd,
12.3 Bayer Healthcare
12.4 Bracco Imaging S.P.A
12.5 Cardinal Health
12.6 Digirad
12.7 Eczcibasi-Monrol Nuclear Products
12.8 GE Healthcare
12.9 IBA Molecular Imaging
12.10 Lantheus Medical Imaging
12.11 Mallinckrodt PLC
12.12 Mediso Ltd.
12.13 Nordion, Inc.
12.14 Philips Healthcare
12.15 Siemens Healthcare
Table of Contents
1 Global Nuclear Medicine Market Outlook, By Region (2013-2022) ($MN)
2 Global Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
3 Global Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
4 Global Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
5 Global Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
6 Global Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
7 Global Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
8 Global Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
9 Global Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
10 Global Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
11 Global Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
12 Global Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
13 Global Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
14 Global Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
15 Global Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
16 Global Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
17 Global Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
18 Global Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
19 Global Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
20 Global Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
21 Global Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
22 Global Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
23 Global Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
24 Global Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
25 Global Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
26 Global Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
27 Global Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
28 Global Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
29 Global Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
30 Global Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
31 Global Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
32 Global Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
33 Global Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
34 Global Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
35 Global Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
36 Global Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
37 Global Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
38 Global Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
39 Global Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
40 Global Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
41 Global Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
42 Global Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
43 Global Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
44 North America Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
45 North America Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
46 North America Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
47 North America Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
48 North America Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
49 North America Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
50 North America Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
51 North America Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
52 North America Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
53 North America Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
54 North America Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
55 North America Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
56 North America Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
57 North America Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
58 North America Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
59 North America Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
60 North America Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
61 North America Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
62 North America Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
63 North America Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
64 North America Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
65 North America Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
66 North America Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
67 North America Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
68 North America Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
69 North America Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
70 North America Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
71 North America Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
72 North America Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
73 North America Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
74 North America Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
75 North America Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
76 North America Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
77 North America Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
78 North America Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
79 North America Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
80 North America Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
81 North America Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
82 North America Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
83 North America Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
84 North America Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
85 North America Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
86 North America Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
87 Europe Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
88 Europe Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
89 Europe Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
90 Europe Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
91 Europe Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
92 Europe Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
93 Europe Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
94 Europe Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
95 Europe Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
96 Europe Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
97 Europe Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
98 Europe Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
99 Europe Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
100 Europe Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
101 Europe Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
102 Europe Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
103 Europe Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
104 Europe Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
105 Europe Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
106 Europe Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
107 Europe Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
108 Europe Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
109 Europe Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
110 Europe Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
111 Europe Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
112 Europe Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
113 Europe Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
114 Europe Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
115 Europe Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
116 Europe Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
117 Europe Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
118 Europe Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
119 Europe Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
120 Europe Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
121 Europe Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
122 Europe Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
123 Europe Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
124 Europe Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
125 Europe Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
126 Europe Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
127 Europe Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
128 Europe Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
129 Europe Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
130 Asia Pacific Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
131 Asia Pacific Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
132 Asia Pacific Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
133 Asia Pacific Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
134 Asia Pacific Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
135 Asia Pacific Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
136 Asia Pacific Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
137 Asia Pacific Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
138 Asia Pacific Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
139 Asia Pacific Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
140 Asia Pacific Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
141 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
142 Asia Pacific Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
143 Asia Pacific Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
144 Asia Pacific Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
145 Asia Pacific Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
146 Asia Pacific Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
147 Asia Pacific Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
148 Asia Pacific Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
149 Asia Pacific Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
150 Asia Pacific Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
151 Asia Pacific Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
152 Asia Pacific Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
153 Asia Pacific Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
154 Asia Pacific Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
155 Asia Pacific Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
156 Asia Pacific Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
157 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
158 Asia Pacific Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
159 Asia Pacific Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
160 Asia Pacific Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
161 Asia Pacific Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
162 Asia Pacific Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
163 Asia Pacific Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
164 Asia Pacific Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
165 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
166 Asia Pacific Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
167 Asia Pacific Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
168 Asia Pacific Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
169 Asia Pacific Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
170 Asia Pacific Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
171 Asia Pacific Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
172 Asia Pacific Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
173 RoW Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
174 RoW Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
175 RoW Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
176 RoW Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
177 RoW Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
178 RoW Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
179 RoW Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
180 RoW Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
181 RoW Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
182 RoW Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
183 RoW Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
184 RoW Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
185 RoW Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
186 RoW Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
187 RoW Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
188 RoW Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
189 RoW Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
190 RoW Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
191 RoW Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
192 RoW Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
193 RoW Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
194 RoW Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
195 RoW Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
196 RoW Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
197 RoW Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
198 RoW Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
199 RoW Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
200 RoW Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
201 RoW Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
202 RoW Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
203 RoW Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
204 RoW Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
205 RoW Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
206 RoW Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
207 RoW Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
208 RoW Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
209 RoW Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
210 RoW Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
211 RoW Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
212 RoW Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
213 RoW Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
214 RoW Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
215 RoW Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
【レポート販売概要】
■ タイトル：核医学の世界市場2015-2022■ 英文：Nuclear Medicine - Global Market Outlook (2015-2022)
■ 発行日：2016年6月19日
■ 調査会社：Stratistics MRC
■ 商品コード：SMRC60765
■ 調査対象地域：グローバル
- フィットネスバイクの世界市場2016-2020About the Exercise Bike Market Exercise bikes are a great option to increase stamina and are among the main fitness equipment in cardio fitness regimes. They are used by all level of exercisers, including beginners, intermediate, and advanced levels of users. Exercising bikes focus on strength training of the lower body, and the option to increase or decrease the resistance offered by the bike giv …
- モバイルアプリケーションセキュリティ市場のベンダー比較分析2015Mobile application security provides detailed security analysis of mobile-based applications. It includes custom scans and in-depth vulnerability checks through various testing capabilities, such as Static Application Security Testing (SAST), Dynamic Application Security Testing (DAST), and Interactive Application Security Testing (IAST). Mobile application security empowers the IT security team t …
- ウェアラブル・スキャナーの世界市場2016-2020About the Wearable Scanner Market Wearable scanners are increasingly adopted in many industries, leading to higher revenues for the market. They are widely used in applications related to the healthcare, transportation and logistics, manufacturing, hospitality and entertainment, retail, and services industries because of their ability to capture data accurately and at a high speed. At present, 2D …
- 自動車TJAシステムの世界市場2017-2021About Automotive TJA Systems TJA system is a driver assistance system that assists the driver in navigating through traffic conditions in a hassle-free manner. It is considered as a semi-autonomous feature and is offered as a part of ADAS. It is considered as a modified version of ACC. In ACC, the driver's vehicle can lock onto the vehicle in front and can modulate the vehicle speed depending on t …
- ガラナの世界市場About GuaranaGuarana is a concentrated extract from the seeds of guarana. It is popularly used for weight loss, to enhance athletic performance, and to reduce mental and physical fatigue. It is also used as a stimulant. Technavio’s analysts forecast the global guarana market to grow at a CAGR of 8.18% during the period 2017-2021. [Covered in this report] The report covers the present scenario and …
- Egyptian Electricity Holding Company：発電所及びSWOT分析2013Egyptian Electricity Holding Company - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) …
- マイクログリッドの世界市場2016-2020About Microgrid A microgrid is a smaller version of a conventional centralized electrical grid. It is capable of producing power, distributing it, and controlling the flow of energy supplied to consumers within a specified geography. It can function autonomously or operate parallel with a conventional grid. However, compared with a conventional grid, the power generated by a microgrid is supplied …
- 自動車トランスミッションシステムの世界市場2017-2027：手動変速機（MT）、自動変速機（AT)、デュアルクラッチ変速機（DCT）、無段変速機（CVT）、オートマチックマニュアルトランスミッション（AMT）Visiongain’s new 139 page market analysis report reveals that the automotive transmission market will achieve revenues of $148bn in 2017. Despite the gradual electrification of the global vehicle fleet, the internal combustion engine (ICE) will be the mainstay of vehicle powertrains for at least the next decade. Furthermore, automotive OEMs are under increasing competitive pressure to make vehicle …
- 芝生及び観賞植物用バイオスティミュラント（生物刺激剤）の世界市場Bio stimulants are used in turf and ornamentals to enhance root growth in turf. Using it, turf and ornamentals appear healthy and strong, thereby increasing bio stimulant usage from last few years. The Bio stimulants in turf and ornamentals market were valued at $ 2.2 billion in 2013, to grow at a CAGR of 11.4% annually to reach at $ 3.8 billion by 2018. It constitutes 20.0% of the global Bio stim …
- 世界のMVNO市場予測：MVNO加入者/収益、制度、MVNO形態別分析The telecoms industry has been changing dramatically over the last decade, and Mobile Virtual Network Operators are taking advantage of these changes in order to take as bigger share of the global market as they can. This has attracted an increasing number of companies that have never been involved in telecoms, but see the MVNO business model as a way to fulfil their long term strategy and maximis …
- ポリブタジェン・ラバ(BR)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world polybutadiene rubber market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a t …
- 砂処理システムの世界市場予測（～2022年）“The sand control systems market is projected to grow at a CAGR of 3.78%, from 2017 to 2022.” The sand control systems market is projected to reach USD 2.84 billion by 2022, at a CAGR of 3.78%, from USD 2.36 billion in 2017. Rising oil & gas production, growth in the number of wells to be drilled, increasing drilling activities in Asia Pacific, and high day rates of offshore rigs are the major dri …
- プラストマーの世界市場2016-2020About Plastomers Plastomers are polymer materials that have properties of both plastics and elastomers. When compared with conventional plastics, plastomers are soft and transparent. Plastomers possess narrow molecular weight distribution, which differentiates them from the conventional plastics or elastomers. They offer exceptional toughness and sealing properties. This is the major characteristi …
- データセンターソリューションの世界市場予測The global data center solutions market is estimated to grow from USD 18.56 Billion in 2015 to USD 32.30 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 11.7% during the forecast period. Data center physical capacity management plays an important role in attaining data center efficiency through effective power, cooling and space that supports IT loads and operations. The increasing num …
- 世界のスマートメーター市場動向n/a
